Kevin Gausman’s 5-year, $110 million deal with the Toronto Blue Jays, which began in 2022, is more than just a reminder of a pitcher the San Francisco Giants let leave. It is a clean example of how one offseason decision can ripple through several seasons of roster building, spending, and second-guessing.
After the 2021 season, the Giants did not re-sign Gausman. Instead, they kept operating in a market where long-term pitching commitments have often felt more like a gamble than a plan. That caution is understandable. The Giants have spent years worrying about injury and ineffectiveness when it comes to pitchers, and that concern has shaped more than one major decision.
The pattern behind the decision
The Gausman choice fits into a longer history. The Giants have already lived through long pitching commitments that went in very different directions, from Barry Zito to Tim Lincecum, Matt Cain, Jeff Samardzija, Johnny Cueto and Madison Bumgarner. Some of those deals brought real value. Others became cautionary tales. That is the background for every later move.
So when the Giants passed on Gausman, the issue was not simply whether he was good enough. It was whether they wanted to make another long-term bet on a pitcher in a franchise that had already seen the downside of those bets. The problem is that hesitation does not remove risk. It just changes where the risk lands.
That is why the Gausman decision still matters in the context of later moves involving Carlos Rodón, Alex Cobb and Robbie Ray. The Giants did not stop chasing pitching talent. They just kept doing it in a way that reflected a deep reluctance to fully commit.
What the later moves say
The cost of that approach is visible in the numbers. For 2024, the Giants owe Alex Cobb $10 million. With approximately two months to go in 2026, the article says the Giants will have paid Robbie Ray $16.7 million if he is traded, even though he is almost certainly on the move less than a month before the trade deadline. Those figures do not prove the Giants were wrong in every case, but they do show how expensive pitching caution can become.
There is also a performance layer to this. Ray, for example, is described as being worth only half a win above replacement. At about $2 million per win, that is not the sort of return a team hopes for when it is trying to patch together a rotation around high-end aspirations. The Giants may have avoided one long contract in Gausman, but they did not escape the larger problem of trying to buy pitching without locking in certainty.
That is the real story here: not that the Giants missed Gausman, but that the franchise’s pitching strategy has continued to move between urgency and restraint. Gausman found his answer in Toronto. The Giants found themselves still trying to manage the same old question.
And that is why Blue Jays Vs Giants still works as more than a matchup label. It is a snapshot of how one club’s decision can become another club’s long-running argument with itself.
